The burden of illness and economic evaluation for COPD
- PMID: 12795329
- DOI: 10.1183/09031936.03.00078203
The burden of illness and economic evaluation for COPD
Abstract
In today's cost-conscious environment, understanding the economic implications associated with disease processes and their treatments is as important as understanding their clinical impact. Medical expenditures for treating chronic obstructive pulmonary disease (COPD) and the indirect costs of morbidity can represent a substantial economic and social burden. Very little economic information concerning COPD is available, however, particularly outside of a few very well-developed Western nations. This article will provide an approach for conducting high-quality studies aimed at estimating the economic burden of chronic obstructive pulmonary disease and for making economic evaluations of healthcare interventions aimed at preventing and treating this disease.
Similar articles
-
Economic analysis of the Confronting COPD survey: an overview of results.Respir Med. 2003 Mar;97 Suppl C:S3-14. doi: 10.1016/s0954-6111(03)80020-3. Respir Med. 2003. PMID: 12647938
-
The burden of COPD in the U.K.: results from the Confronting COPD survey.Respir Med. 2003 Mar;97 Suppl C:S71-9. doi: 10.1016/s0954-6111(03)80027-6. Respir Med. 2003. PMID: 12647945
-
The burden of COPD in Italy: results from the Confronting COPD survey.Respir Med. 2003 Mar;97 Suppl C:S43-50. doi: 10.1016/s0954-6111(03)80024-0. Respir Med. 2003. PMID: 12647942
-
The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.COPD. 2010 Jun;7(3):214-28. doi: 10.3109/15412555.2010.481697. COPD. 2010. PMID: 20486821 Review.
-
Chronic obstructive pulmonary disease: the disease and its burden to society.Proc Am Thorac Soc. 2006 Sep;3(7):619-23. doi: 10.1513/pats.200603-093SS. Proc Am Thorac Soc. 2006. PMID: 16963544 Review.
Cited by
-
Application of Discrete Event Simulation Models for COPD Management: A Systematic Review.Int J Chron Obstruct Pulmon Dis. 2025 Mar 12;20:685-698. doi: 10.2147/COPD.S501054. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40092318 Free PMC article.
-
New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.Pharmacoeconomics. 2012 Oct 1;30(10):869-85. doi: 10.2165/11633330-000000000-00000. Pharmacoeconomics. 2012. PMID: 22852587 Free PMC article. Review.
-
Utility estimation in chronic obstructive pulmonary disease: a preference for change?Pharmacoeconomics. 2011 Nov;29(11):917-32. doi: 10.2165/11589280-000000000-00000. Pharmacoeconomics. 2011. PMID: 21988291
-
Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.Int J Chron Obstruct Pulmon Dis. 2008;3(4):671-82. doi: 10.2147/copd.s4950. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 19281082 Free PMC article. Review.
-
Content Validity of the Comprehensive ICF Core Set for Chronic Obstructive Pulmonary Diseases: An International Delphi Survey.Open Respir Med J. 2013 Apr 5;7:33-45. doi: 10.2174/1874306401307010033. Print 2013. Open Respir Med J. 2013. PMID: 23730367 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical